Jul 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Jun 30, 2022 Jun 30, 2021 Mar 31, 2023
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 1.24 1.17 5.00
(+6.1 pct) (+18.3 pct) (+8.3 pct)
Operating 292 mln 279 mln 800 mln
(+4.8 pct) (+73.1 pct) (+7.0 pct)
Recurring 298 mln 281 mln 800 mln
(+6.1 pct) (+69.4 pct) (+2.8 pct)
Net 201 mln 193 mln 520 mln
(+4.3 pct) (+55.3 pct) (+1.5 pct)
EPS 48.28 yen 47.20 yen 128.28 yen
Ann Div 25.00 yen 25.00 yen
-Q2 div NIL NIL
-Q4 div 25.00 yen 25.00 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T